Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Notes Payables (2020 - 2025)

Selectis Health's Notes Payables history spans 10 years, with the latest figure at $775000.0 for Q4 2025.

  • Quarterly results put Notes Payables at $775000.0 for Q4 2025, up 3.33% from a year ago — trailing twelve months through Dec 2025 was $775000.0 (up 3.33% YoY), and the annual figure for FY2025 was $775000.0, up 3.33%.
  • Notes Payables for Q4 2025 was $775000.0 at Selectis Health, roughly flat from $775000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $2.3 million in Q2 2022 to a low of $150000.0 in Q4 2021.
  • The 5-year median for Notes Payables is $775000.0 (2025), against an average of $754006.6.
  • Peak annual rise in Notes Payables hit 858.74% in 2023, while the deepest fall reached 93.42% in 2023.
  • Year by year, Notes Payables stood at $150000.0 in 2021, then skyrocketed by 500.0% to $900000.0 in 2022, then changed by 0.0% to $900000.0 in 2023, then dropped by 16.67% to $750000.0 in 2024, then rose by 3.33% to $775000.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods came in at $775000.0, $775000.0, and $775000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.